EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer

Guo Li, Lingping Kong iD, Shasha Guan, Lu Xu, Jing Wang, Diansheng Zhong, Linlin Zhang

Cancer Immunology, Immunotherapy · 01.08.2026 · 75 (11)

DOI: 10.1007/s00262-026-04496-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 01.08.2026. Verfasst von Guo Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Ataxia Telangiectasia Mutated Proteins, Lung Neoplasms, NF-kappa B. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungAtaxia Telangiectasia Mutated ProteinsLung NeoplasmsNF-kappa BProtein Serine-Threonine KinasesImmunotherapyAnimalsHumansMiceAutophagySignal TransductionMice, Inbred C57BLCell Line, Tumor

Stichwörter der Autor:innen

ATR inhibitionMHC-ITBK1-NFκBautophagyimmunotherapynon-small cell lung cancer

Substanzen

Ataxia Telangiectasia Mutated ProteinsNF-kappa BProtein Serine-Threonine KinasesATR protein, humanTBK1 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China.
  • Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. dzhong@tmu.edu.cn.
  • Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, 300052, China. zllcaroline@tmu.edu.cn.

ORCID-Profile: Lingping Kong

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, G., Kong, L., Guan, S., Xu, L., Wang, J., Zhong, D., & Zhang, L. (2026). ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer. Cancer Immunology, Immunotherapy, 75(11). https://doi.org/10.1007/s00262-026-04496-8

Vancouver

Li G, Kong L, Guan S, Xu L, Wang J, Zhong D, et al. ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer. Cancer Immunology, Immunotherapy. 2026;75(11). doi:10.1007/s00262-026-04496-8

BibTeX
@article{Li2026,
  author = {Li, Guo and Kong, Lingping and Guan, Shasha and Xu, Lu and Wang, Jing and Zhong, Diansheng and Zhang, Linlin},
  title = {ATR inhibition potentiates immunotherapy efficacy via TBK1-NFκB signaling and autophagy blockade in non-small cell lung cancer},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {11},
  doi = {10.1007/s00262-026-04496-8}
}
Kostenlos starten →